Risk-Based Comparison of Antiplatelet Monotherapies After PCI
In a post hoc analysis of the HOST-EXAM (Harmonizing Optimal Strategy for Treatment of coronary artery diseases—EXtended Antiplatelet Monotherapy) trial, clopidogrel had consistently better outcomes